filmov
tv
Welcome Remarks & Plenary Session: Lessons from Pioneers of Cell & Gene Therapy Commercialization
Показать описание
WELCOME REMARKS
Speakers:
Janet Lambert, CEO, Alliance for Regenerative Medicine (ARM)
Robert Preti, Ph.D., Chairman, Alliance for Regenerative Medicine (ARM); President and CEO, Hitachi Chemical Advanced Therapeutics Solutions; GM, Hitachi Chemical Regenerative Medicine Business Sector
PLENARY SESSION: CHARTING THE PATH – LESSONS FROM THE PIONEERS OF CELL AND GENE THERAPY COMMERCIALIZATION
This session will explore how far we have come in recent years with the approval of the first gene and cell therapy products and a burgeoning industry pipeline expected to produce numerous additional new therapies in the coming years. Executives from three of the companies who have been at the forefront of cell and gene medicine will share their perspectives on the major scientific, regulatory and technical developments of recent years that have contributed most to the sector’s current success.
Chair:
Robert Preti, Ph.D., President and CEO, Hitachi Chemical Advanced Therapeutics Solutions; GM, Hitachi Chemical Regenerative Medicine Business Sector
Speakers:
David Lennon, Ph.D., President, AveXis
Ron Philip, SVP, Head of Global Commercial, Spark Therapeutics
Pascal Touchon, SVP and Global Head, Cell and Gene, Novartis Oncology
Speakers:
Janet Lambert, CEO, Alliance for Regenerative Medicine (ARM)
Robert Preti, Ph.D., Chairman, Alliance for Regenerative Medicine (ARM); President and CEO, Hitachi Chemical Advanced Therapeutics Solutions; GM, Hitachi Chemical Regenerative Medicine Business Sector
PLENARY SESSION: CHARTING THE PATH – LESSONS FROM THE PIONEERS OF CELL AND GENE THERAPY COMMERCIALIZATION
This session will explore how far we have come in recent years with the approval of the first gene and cell therapy products and a burgeoning industry pipeline expected to produce numerous additional new therapies in the coming years. Executives from three of the companies who have been at the forefront of cell and gene medicine will share their perspectives on the major scientific, regulatory and technical developments of recent years that have contributed most to the sector’s current success.
Chair:
Robert Preti, Ph.D., President and CEO, Hitachi Chemical Advanced Therapeutics Solutions; GM, Hitachi Chemical Regenerative Medicine Business Sector
Speakers:
David Lennon, Ph.D., President, AveXis
Ron Philip, SVP, Head of Global Commercial, Spark Therapeutics
Pascal Touchon, SVP and Global Head, Cell and Gene, Novartis Oncology
0:05:42
0:09:09
1:15:03
0:04:34
1:31:11
0:37:26
0:30:04
0:02:03
1:26:50
0:03:09
0:01:31
0:04:32
1:56:25
0:13:18
0:04:47
0:02:05
0:29:59
0:20:33
0:58:24
0:14:12
1:09:59
0:46:05
1:35:24
2:00:03